Drugs / iNO
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT03602781 Comparator | Aug 2018 → Jun 2019 | pulmonary arterial hypertension | Bellerophon Pulse Technologies | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | iNO | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03602781 ↗ |
| Route | Inhaled | “Inhaled Nitric Oxide” NCT03602781 ↗ |